This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Reply to “Comments on a Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting

Matthew J. Friedman, MD, PhD; Charles R. Marmar, MD; Dewleen G. Baker, MD; Carolyn R. Sikes, PhD; and Gail M. Farfel, PhD

Published: March 18, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We certainly agree with Dr. Hussain that more researchis needed regarding responsivity of patients with combat-related(compared to non-combat-related) posttraumatic stress disorder(PTSD) to selective serotonin reuptake inhibitors (SSRIs), othermedications, and psychotherapy. We also agree that further researchon predictors of response would be very useful.We recognize that negative results among chronic Vietnamveterans in Department of Veterans Affairs (VA) settings haveprompted speculation that combat-related PTSD is somehowdifferent and less treatment responsive than non-combat-relatedPTSD.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 69

Quick Links: